Duchenne Muscular Dystrophy

2 End Of May FDA Decisions To Watch
Seeking Alpha
Mon, 05/23/16 - 07:03 pm
FDA
Sarepta Therapeutics
Titan Pharmaceuticals
Duchenne Muscular Dystrophy
eteplirsen
Probuphine
opioid addiction
2 Hotly Debated Drugs Due For FDA Decisions Next Week
Investors.com
Sat, 05/21/16 - 12:35 pm
FDA
Sarepta Therapeutics
Duchenne Muscular Dystrophy
Intercept Pharma
Ocaliva
liver disease
primary biliary cholangitis
What's Sarepta Therapeutics Inc.'s Next Move?
Motley Fool
Tue, 05/10/16 - 09:43 am
Sarepta Therapeutics
Duchenne Muscular Dystrophy
eteplirsen
​Wave to begin trials next year on 'more efficient' drug for Duchenne
Bizjournals.com
Mon, 05/9/16 - 01:52 pm
Wave Life Sciences
Duchenne Muscular Dystrophy
Sarepta: The Path Forward
Seeking Alpha
Wed, 05/4/16 - 08:52 am
Sarepta Therapeutics
Duchenne Muscular Dystrophy
eteplirsen
​Why it took so long for Sarepta to start a big trial of its Duchenne drug
Bizjournals.com
Tue, 05/3/16 - 05:15 pm
Sarepta Therapeutics
Duchenne Muscular Dystrophy
eteplirsen
clinical trials
Sarepta Therapeutics shares surge 20% after article suggests drug approval possible
Marketwatch
Thu, 04/28/16 - 09:36 am
Sarepta Therapeutics
Duchenne Muscular Dystrophy
FDA
advisory panels
eteplirsen
Here Are Three Ways To Prevent Tragic Battles Between The FDA And Patients
Forbes
Wed, 04/27/16 - 09:06 am
FDA
patients
Sarepta Therapeutics
eteplirsen
Duchenne Muscular Dystrophy
Biotech stock crashes 50% after disclosing bad news from the FDA
Yahoo/Business Insider
Tue, 04/26/16 - 09:45 am
Sarepta Therapeutics
eteplirsen
FDA
Duchenne Muscular Dystrophy
FDA panel votes against Sarepta’s drug for Duchenne muscular dystrophy
Stat
Mon, 04/25/16 - 09:57 pm
FDA
Sarepta Therapeutics
eteplirsen
advisory panels
Duchenne Muscular Dystrophy
Sarepta Therapeutics FDA Panel Live Blog
TheStreet.com
Mon, 04/25/16 - 08:21 am
Sarepta Therapeutics
eteplirsen
FDA
advisory panels
Duchenne Muscular Dystrophy
An Investors' Guide to Sarepta's Eteplirsen FDA Advisory Panel Meeting
TheStreet.com
Mon, 04/25/16 - 07:56 am
Sarepta Therapeutics
eteplirsen
FDA
advisory panels
Duchenne Muscular Dystrophy
Could Desperate Parents' Pleas Sway The FDA To Approve A Drug Even If Evidence It Works Is Lacking?
Forbes
Sun, 04/24/16 - 04:32 pm
FDA
parents
Duchenne Muscular Dystrophy
Sarepta Therapeutics
eteplirsen
Sarepta shares soar on FDA voting questions
CNBC
Fri, 04/22/16 - 09:38 pm
Sarepta
FDA
eteplirsen
Duchenne Muscular Dystrophy
Biotech Stock Mailbag: Is There a Future for Sarepta Therapeutics?
TheStreet.com
Fri, 04/22/16 - 10:40 am
Sarepta Therapeutics
eteplirsen
Duchenne Muscular Dystrophy
FDA Still Negative on Sarepta's DMD Drug, Stock Price Sinks
TheStreet.com
Thu, 04/21/16 - 08:45 am
FDA
Sarepta Therapeutics
Duchenne Muscular Dystrophy
eteplirsen
2 FDA Actions To Watch In April
Seeking Alpha
Mon, 03/28/16 - 09:12 pm
FDA
Sarepta Therapeutics
eteplirsen
Mycapssa
Chiasma
acromegaly
Duchenne Muscular Dystrophy
Summit develops a unique Duchenne drug for any gene mutation
Bizjournals.com
Sat, 03/26/16 - 12:59 pm
Summit Therapeutics
Sarepta Therapeutics
Duchenne Muscular Dystrophy
Sarepta surges as a group of expert doctors endorses its investigational DMD drug
Bidness, ETC
Tue, 03/22/16 - 10:00 am
physicians
Sarepta Therapeutics
Duchenne Muscular Dystrophy
eteplirsen
​FDA sets new date for hearing on Sarepta’s Duchenne drug
Bizjournals.com
Thu, 03/10/16 - 09:57 am
FDA
Sarepta Therapeutics
Duchenne Muscular Dystrophy
eteplirsen

Pages